Skip to main content
PMC home page
Journal of Medical Toxicology logoLink to Journal of Medical Toxicology
. 2005 Dec;1(1):30–34. doi: 10.1007/BF03160903

Issues in the management of dietary supplement use among hospitalized patients

Edward W Boyer 1,2,✉
PMCID: PMC3550008  PMID: 18072101

Abstract

Herbs and dietary supplements (HDS) are in widespread use in the United States, and are especially prevalent among chronically ill patients. This population is more likely to be admitted to health care facilities where they may continue to use HDS. The risk of adverse effects from HDS used during admission places significant liability on clinicians and hospitals. We describe the response of health care facilities in the Boston, Massachusetts area to this problem, and propose elements of a hospital policy which increases patient safety and satisfaction and minimizes the likelihood for adverse effects from HDS.

Keywords: dietary supplements, drug interactions, inpatients

Full Text

The Full Text of this article is available as a PDF (100.2 KB).

References

  • 1.Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993;328:246–52. doi: 10.1056/NEJM199301283280406. [DOI] [PubMed] [Google Scholar]
  • 2.Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA. 1998;280:1569–75. doi: 10.1001/jama.280.18.1569. [DOI] [PubMed] [Google Scholar]
  • 3.Bennet J, Brown C. Use of herbal remedies by patients in a health maintenance organization. J Am Pharm Assoc. 2000;40:353–358. doi: 10.1016/s1086-5802(16)31082-8. [DOI] [PubMed] [Google Scholar]
  • 4.Elder N, Gillchrist A, Minz R. Use of alternative health care by family practice patients. Arch Fam Med. 1997;6:181–184. doi: 10.1001/archfami.6.2.181. [DOI] [PubMed] [Google Scholar]
  • 5.Shannon M. Herbal, traditional, and alternative medicine. In: Haddad LM SM, Winchester J, editors. Clinical Management of Poisoning and Drug Overdose. Philadelphia: WB Saunders; 1998. [Google Scholar]
  • 6.Ko R. Causes, epidemiology, and clinical evaluation of suspected herbal poisoning. Journal of toxicology-Clinical toxicology. 1999;37:697–708. doi: 10.1081/CLT-100102447. [DOI] [PubMed] [Google Scholar]
  • 7.Astin J. Why patients use alternative medicines. JAMA. 1998;279:1548–1552. doi: 10.1001/jama.279.19.1548. [DOI] [PubMed] [Google Scholar]
  • 8.Shannon M. Symposium on natural products toxicology. Journal of Toxicology-Clinical Toxicology. 1999;37:695–696. [PubMed] [Google Scholar]
  • 9.Committee on Children With Disabilities Counseling families who choose complementary and alternative medicine for their child with chronic illness and disability. Pediatrics. 2001;107:598–601. [PubMed] [Google Scholar]
  • 10.Walker P. Evolution of a policy disallowing the use of alternative therapies in a health system. Am J Health-Syst Pharm. 2000;57:1984–1990. doi: 10.1093/ajhp/57.21.1984. [DOI] [PubMed] [Google Scholar]
  • 11.Dietary Supplement Health and Education Act of 1994. Pub. L. 103–417, 108 Stat. 4325,1994.
  • 12.Shannon M. Alternative medicines toxicology: A review of selected agents. Journal of Toxicology-Clinical Toxicology. 1999;37:709–713. doi: 10.1081/CLT-100102448. [DOI] [PubMed] [Google Scholar]
  • 13.Robbers J, Tyler V. The therapeutic use of phytomedicinals. In: Tyler V, editor. Tyler’s herbs of choice. New York: Hawthorne Herbal; 1999. [Google Scholar]
  • 14.Ko R. Adulterants in Asian patent medicines. N Engl J Med. 1998;339:847–847. doi: 10.1056/NEJM199809173391214. [DOI] [PubMed] [Google Scholar]
  • 15.Hung O, Shih R, Howland M. Herbal preparations. In: Goldfrank L, editor. Goldfrank’s Toxicologic Emergencies. Stamford, CT: Appleton and Lange; 1998. pp. 1221–1238. [Google Scholar]
  • 16.Espinoza EO, Mann M-J, Bleasdell B. Arsenic and mercury in traditional Chinese herbal balls. New Engl J Med. 1995;333:803–804. doi: 10.1056/NEJM199509213331217. [DOI] [PubMed] [Google Scholar]
  • 17.Lau K, Lai C, Chan A. Phenytoin poisoning after using a Chinese proprietary medicine. Hum Exp Toxicol. 2000;19:385–386. doi: 10.1191/096032700678816115. [DOI] [PubMed] [Google Scholar]
  • 18.Spigelblatt L, Laine-Amamara G, Pless I, Guyver A. The use of alternative medicine by children. Pediatrics. 1994;94:811–814. [PubMed] [Google Scholar]
  • 19.Stern R, Canda E, Doershuk D. Use of nonmedical treatment by cystic fibrosis patients. J Adolesc Health. 1992;13:612–615. doi: 10.1016/1054-139X(92)90376-M. [DOI] [PubMed] [Google Scholar]
  • 20.Hung O, Shih R, Chiang W, Nelson L, Hoffman R, Goldfrank L. Herbal Medication Use Among Urban Emergency Department Patients. Acad Emerg Med. 1997;4:209–213. doi: 10.1111/j.1553-2712.1997.tb03743.x. [DOI] [PubMed] [Google Scholar]
  • 21.Bausell R, Lee W, Berman B. Demographic and health-related correlates to visits to complementary and alternative medicine providers. Med Care. 2001;39:190–196. doi: 10.1097/00005650-200102000-00009. [DOI] [PubMed] [Google Scholar]
  • 22.Fernandez T, Slayton W, Allen L. Use of alternative therapies for children with cancer. Pediatrics. 1997;100:1–1. doi: 10.1542/peds.100.1.1. [DOI] [PubMed] [Google Scholar]
  • 23.Kestin M, Miller L, Littlejohn G, Wahlqvist M. The use of unproven remedies for rheumatoid arthritis in Australia. Med J Aust. 1985;143:516–518. doi: 10.5694/j.1326-5377.1985.tb119916.x. [DOI] [PubMed] [Google Scholar]
  • 24.Southwood T, Malleson P, Roberts-Thompson P, Mahy M. Unconventional remedies used for patients with juvenile arthritis. Pediatrics. 1990;85:150–4. [PubMed] [Google Scholar]
  • 25.Stern R, Canda E, Doershuk C. Use of nonmedical treatment b cystic fibrosis patients. J Adolesc Health1992; 13. [DOI] [PubMed]
  • 26.Fairfield K, Eisenberg D, Davis R, Libman H, Phillips R. Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med. 1994;158:2257–2264. doi: 10.1001/archinte.158.20.2257. [DOI] [PubMed] [Google Scholar]
  • 27.Fernandez C, Stutzer C, MacWilliam L, Fryer C. Alternative and complementary therapy use in pediatric oncology patients in British Columbia: Prevalence and reasons for use and nonuse. J Clin Oncol. 1998;16:1279–1286. doi: 10.1200/JCO.1998.16.4.1279. [DOI] [PubMed] [Google Scholar]
  • 28.Hensrud D, Engle D, Scheitel S. Underreporting the use of dietary supplements and nonprescription medications among patients undergoing a periodic health examination. Mayo Clin Proc. 1999;74:443–447. doi: 10.4065/74.5.443. [DOI] [PubMed] [Google Scholar]
  • 29.Sibinga E, Ottolini M, Duggan A, Wilson M. Communication about complementary/alternative medicine use in children. Pediatr Res. 2000;47:226A–226A. doi: 10.1177/000992280404300408. [DOI] [PubMed] [Google Scholar]
  • 30.Fraenkel M, Arye E. The growing need to teach about complementary and alternative medicines: questions and challenges. Acad Med. 2001;76:251–254. doi: 10.1097/00001888-200103000-00012. [DOI] [PubMed] [Google Scholar]
  • 31.McCann G. Alternative medicines starting to penetrate hospital DURs. Hosp Pharm Rep. 1997;11:48–90. [Google Scholar]
  • 32.Beal F. Herbals and homeopathic remedies as formulary items? Am J Health-Syst Pharm. 1998;55:1266–1267. doi: 10.1093/ajhp/55.12.1266. [DOI] [PubMed] [Google Scholar]
  • 33.Rich D. Point-of-care automated dispensing devices: herbal products, proper medication orders; expiration dating. Hosp Pharm. 1999;34:989–995. [Google Scholar]
  • 34.Boozang K. Western medicine opens the door to alternative medicine. Am J Law Med. 1998;24:185–212. [PubMed] [Google Scholar]
  • 35.Boyer EW. 2000 Poisoning Data: Massachusetts Poison Control Center,2000.
  • 36.Boyer EW, Kearney S, Woolf A, Shannon M, Kemper K. Poisoning from a dietary supplement administered during hospitalization. Pediatrics. 2002;109:e49–e49. doi: 10.1542/peds.109.3.e49. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Toxicology are provided here courtesy of Springer

RESOURCES